Bausch + Lomb Announces Board Changes
VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that the Am...
Could the removal of Icahnâs influence signal a shift in the company's stance toward activist investors and affect longâterm shareholder value?
What is the expected shortâterm impact of this board change on BLCO's share price and trading volume?
How will the termination of Carl Icahn's director appointment agreement affect Bausch + Lomb's governance and future strategic direction?
1 day ago